Avricore Health Inc. Logo

Avricore Health Inc.

AVCRF

(1.0)
Stock Price

0,04 USD

-0.11% ROA

4.59% ROE

-6169.76x PER

Market Cap.

18.146.578,72 USD

0% DER

0% Yield

2.19% NPM

Avricore Health Inc. Stock Analysis

Avricore Health Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Avricore Health Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (2%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Revenue Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

3 ROE

Negative ROE (-52.06%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-33.94%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

5 PBV

The stock's high Price-to-Book Value (P/BV) ratio (9.53x) suggests it's overvalued, potentially making it an expensive investment.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Avricore Health Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Avricore Health Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Buy
4 Stoch RSI Buy

Avricore Health Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Avricore Health Inc. Revenue
Year Revenue Growth
2001 0
2002 3.579 100%
2003 4.933 27.45%
2004 111.363 95.57%
2005 239.271 53.46%
2006 223.586 -7.02%
2007 256.243 12.74%
2008 249.042 -2.89%
2009 282.261 11.77%
2010 1.459.686 80.66%
2011 305.592 -377.66%
2012 83.361 -266.59%
2013 83.361 0%
2014 83.361 0%
2015 5.713 -1359.15%
2016 1.013.690 99.44%
2017 537.714 -88.52%
2018 226.445 -137.46%
2019 33.000 -586.2%
2020 33.030 0.09%
2021 122.808 73.1%
2022 1.768.374 93.06%
2023 3.813.816 53.63%
2023 3.485.147 -9.43%
2024 4.180.824 16.64%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Avricore Health Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2001 0
2002 0 0%
2003 0 0%
2004 2.100 100%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 189.556 100%
2010 223.263 15.1%
2011 76.524 -191.76%
2012 31.886 -139.99%
2013 10.162 -213.78%
2014 34.729 70.74%
2015 56.143 38.14%
2016 208.784 73.11%
2017 242.303 13.83%
2018 251.508 3.66%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Avricore Health Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2001 2.787
2002 0 0%
2003 0 0%
2004 501.590 100%
2005 604.637 17.04%
2006 476.598 -26.87%
2007 631.197 24.49%
2008 2.031.650 68.93%
2009 1.107.091 -83.51%
2010 1.403.521 21.12%
2011 1.360.059 -3.2%
2012 434.083 -213.32%
2013 181.793 -138.78%
2014 735.566 75.29%
2015 1.650.687 55.44%
2016 1.651.926 0.08%
2017 1.666.213 0.86%
2018 1.526.444 -9.16%
2019 1.301.290 -17.3%
2020 845.636 -53.88%
2021 1.706.200 50.44%
2022 1.005.632 -69.66%
2023 1.917.328 47.55%
2023 1.842.714 -4.05%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Avricore Health Inc. EBITDA
Year EBITDA Growth
2001 -12.551
2002 -68.938 81.79%
2003 -52.736 -30.72%
2004 -354.680 85.13%
2005 -299.811 -18.3%
2006 -446.511 32.85%
2007 -556.354 19.74%
2008 -1.925.049 71.1%
2009 -1.255.217 -53.36%
2010 -4.055.920 69.05%
2011 -1.865.906 -117.37%
2012 -384.247 -385.6%
2013 -192.545 -99.56%
2014 -770.295 75%
2015 -1.713.340 55.04%
2016 -2.035.122 15.81%
2017 -1.972.994 -3.15%
2018 -2.346.339 15.91%
2019 -1.420.033 -65.23%
2020 -859.154 -65.28%
2021 -1.727.024 50.25%
2022 -626.812 -175.53%
2023 -646.324 3.02%
2023 -271.770 -137.82%
2024 1.699.208 115.99%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Avricore Health Inc. Gross Profit
Year Gross Profit Growth
2001 0
2002 3.579 100%
2003 4.933 27.45%
2004 -11.479 142.97%
2005 89.196 112.87%
2006 81.207 -9.84%
2007 90.323 10.09%
2008 91.808 1.62%
2009 57.574 -59.46%
2010 209.247 72.49%
2011 49.703 -320.99%
2012 83.361 40.38%
2013 83.361 0%
2014 12.305 -577.46%
2015 3.222 -281.91%
2016 302.778 98.94%
2017 246.843 -22.66%
2018 38.051 -548.72%
2019 14.498 -162.46%
2020 17.480 17.06%
2021 30.521 42.73%
2022 456.793 93.32%
2023 1.047.112 56.38%
2023 1.201.049 12.82%
2024 1.483.100 19.02%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Avricore Health Inc. Net Profit
Year Net Profit Growth
2001 -12.551
2002 -69.590 81.96%
2003 -53.479 -30.13%
2004 -731.479 92.69%
2005 -796.301 8.14%
2006 -378.301 -110.49%
2007 -562.090 32.7%
2008 -1.937.735 70.99%
2009 -1.183.009 -63.8%
2010 -3.992.659 70.37%
2011 -1.875.565 -112.88%
2012 -306.565 -511.8%
2013 283.432 208.16%
2014 -733.946 138.62%
2015 -2.200.648 66.65%
2016 -2.613.904 15.81%
2017 -3.486.324 25.02%
2018 -5.391.654 35.34%
2019 -2.112.848 -155.18%
2020 -1.332.918 -58.51%
2021 -1.746.570 23.68%
2022 -826.597 -111.3%
2023 -1.140.248 27.51%
2023 -701.215 -62.61%
2024 216.088 424.5%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Avricore Health Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2001 0
2002 -1 100%
2003 -1 0%
2004 -3 100%
2005 -2 -50%
2006 -1 0%
2007 -1 100%
2008 -2 0%
2009 -1 0%
2010 -3 100%
2011 -1 -100%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Avricore Health Inc. Free Cashflow
Year Free Cashflow Growth
2001 -10.481
2002 -75.660 86.15%
2003 13.737 650.78%
2004 -782.077 101.76%
2005 -405.358 -92.93%
2006 -314.656 -28.83%
2007 -415.273 24.23%
2008 -933.684 55.52%
2009 -931.462 -0.24%
2010 -3.614.682 74.23%
2011 -673.340 -436.83%
2012 -58.663 -1047.81%
2013 -186.467 68.54%
2014 -571.379 67.37%
2015 -1.515.423 62.3%
2016 -2.070.430 26.81%
2017 -1.771.080 -16.9%
2018 -1.780.047 0.5%
2019 -686.407 -159.33%
2020 -1.223.396 43.89%
2021 -1.374.518 10.99%
2022 -1.636.348 16%
2023 -82.840 -1875.31%
2023 -386.456 78.56%
2024 -29.431 -1213.09%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Avricore Health Inc. Operating Cashflow
Year Operating Cashflow Growth
2001 -10.481
2002 -73.060 85.65%
2003 14.043 620.26%
2004 -755.460 101.86%
2005 -404.716 -86.66%
2006 -314.656 -28.62%
2007 -371.023 15.19%
2008 -876.722 57.68%
2009 -930.623 5.79%
2010 -3.612.059 74.24%
2011 -673.340 -436.44%
2012 -58.663 -1047.81%
2013 -154.607 62.06%
2014 -539.519 71.34%
2015 -1.484.577 63.66%
2016 -2.064.090 28.08%
2017 -1.767.296 -16.79%
2018 -1.725.047 -2.45%
2019 -686.407 -151.32%
2020 -1.223.396 43.89%
2021 -1.234.154 0.87%
2022 -437.832 -181.88%
2023 184.568 337.22%
2023 660.403 72.05%
2024 11.060 -5871.09%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Avricore Health Inc. Capital Expenditure
Year Capital Expenditure Growth
2001 0
2002 2.600 100%
2003 306 -749.67%
2004 26.617 98.85%
2005 642 -4045.95%
2006 0 0%
2007 44.250 100%
2008 56.962 22.32%
2009 839 -6689.27%
2010 2.623 68.01%
2011 0 0%
2012 0 0%
2013 31.860 100%
2014 31.860 0%
2015 30.846 -3.29%
2016 6.340 -386.53%
2017 3.784 -67.55%
2018 55.000 93.12%
2019 0 0%
2020 0 0%
2021 140.364 100%
2022 1.198.516 88.29%
2023 267.408 -348.2%
2023 1.046.859 74.46%
2024 40.491 -2485.41%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Avricore Health Inc. Equity
Year Equity Growth
2001 79.949
2002 184.418 56.65%
2003 182.984 -0.78%
2004 800.222 77.13%
2005 271.028 -195.25%
2006 157.368 -72.23%
2007 779.898 79.82%
2008 2.476.054 68.5%
2009 1.725.883 -43.47%
2010 239.296 -621.23%
2011 -1.066.502 122.44%
2012 -1.321.164 19.28%
2013 436.688 402.54%
2014 663.097 34.14%
2015 3.353.461 80.23%
2016 1.917.993 -74.84%
2017 2.498.097 23.22%
2018 885.966 -181.96%
2019 -465.451 290.35%
2020 -714.041 34.81%
2021 2.196.916 132.5%
2022 1.964.090 -11.85%
2023 1.806.638 -8.72%
2023 2.008.986 10.07%
2024 2.277.208 11.78%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Avricore Health Inc. Assets
Year Assets Growth
2001 83.982
2002 189.773 55.75%
2003 286.544 33.77%
2004 830.764 65.51%
2005 300.893 -176.1%
2006 216.872 -38.74%
2007 854.166 74.61%
2008 2.533.975 66.29%
2009 1.782.098 -42.19%
2010 1.353.067 -31.71%
2011 190.494 -610.29%
2012 19.751 -864.48%
2013 800.991 97.53%
2014 820.418 2.37%
2015 3.540.585 76.83%
2016 2.275.335 -55.61%
2017 2.900.186 21.55%
2018 1.200.205 -141.64%
2019 208.399 -475.92%
2020 440.090 52.65%
2021 2.281.393 80.71%
2022 2.568.983 11.19%
2023 2.453.136 -4.72%
2023 2.538.205 3.35%
2024 2.618.384 3.06%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Avricore Health Inc. Liabilities
Year Liabilities Growth
2001 4.033
2002 5.355 24.69%
2003 103.560 94.83%
2004 30.542 -239.07%
2005 29.865 -2.27%
2006 59.504 49.81%
2007 74.268 19.88%
2008 57.921 -28.22%
2009 56.215 -3.03%
2010 1.113.771 94.95%
2011 1.256.996 11.39%
2012 1.340.915 6.26%
2013 364.303 -268.08%
2014 157.321 -131.57%
2015 187.124 15.93%
2016 357.342 47.63%
2017 402.089 11.13%
2018 314.239 -27.96%
2019 673.850 53.37%
2020 1.154.131 41.61%
2021 84.477 -1266.21%
2022 604.893 86.03%
2023 646.498 6.44%
2023 529.218 -22.16%
2024 341.176 -55.12%

Avricore Health Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.04
Net Income per Share
-0
Price to Earning Ratio
-6169.76x
Price To Sales Ratio
4.05x
POCF Ratio
21.2
PFCF Ratio
187.78
Price to Book Ratio
7.91
EV to Sales
3.93
EV Over EBITDA
23.92
EV to Operating CashFlow
20.7
EV to FreeCashFlow
182.03
Earnings Yield
-0
FreeCashFlow Yield
0.01
Market Cap
0,02 Bil.
Enterprise Value
0,02 Bil.
Graham Number
0
Graham NetNet
0

Income Statement Metrics

Net Income per Share
-0
Income Quality
-291.09
ROE
-0
Return On Assets
0.03
Return On Capital Employed
0.12
Net Income per EBT
1
EBT Per Ebit
0.34
Ebit per Revenue
0.06
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0.37
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.11
Gross Profit Margin
0.38
Operating Profit Margin
0.06
Pretax Profit Margin
0.02
Net Profit Margin
0.02

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.01
Free CashFlow per Share
0
Capex to Operating CashFlow
0.89
Capex to Revenue
0.17
Capex to Depreciation
1.59
Return on Invested Capital
-2.33
Return on Tangible Assets
-0
Days Sales Outstanding
26.85
Days Payables Outstanding
37.79
Days of Inventory on Hand
1.15
Receivables Turnover
13.59
Payables Turnover
9.66
Inventory Turnover
316.18
Capex per Share
0.01

Balance Sheet

Cash per Share
0,01
Book Value per Share
0,02
Tangible Book Value per Share
0.02
Shareholders Equity per Share
0.02
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
-0.76
Current Ratio
2.79
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
2277208
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.02
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
9045
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Avricore Health Inc. Dividends
Year Dividends Growth

Avricore Health Inc. Profile

About Avricore Health Inc.

Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a lab-accurate point of care testing platform for pharmacy. The company has strategic partnerships with Shoppers Drug Marts and Abbott. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

CEO
Mr. Hector Bremner
Employee
0
Address
789 West Pender Street
Vancouver, V6C 1H2

Avricore Health Inc. Executives & BODs

Avricore Health Inc. Executives & BODs
# Name Age
1 Ms. Kiriaki Smith CPA, CFO, CGA, CPA
Chief Financial Officer & Corporate Secretary
70
2 Mr. Hector Bremner
Chief Executive Officer & Director
70
3 Mr. Rodger Seccombe
Chief Technology Officer & Director
70
4 Mr. Will Seccombe
Communications Advisor
70

Avricore Health Inc. Competitors